Menu
← Oncology Approval Tracker
FDA DECISION ·
Xeloda + combination chemotherapy
capecitabine with combination chemotherapy · Genentech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Part of combination chemotherapy for adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer.
LAMPGEN ANALYSIS
Why it matters
Project Renewal adds a broad upper gastrointestinal use for capecitabine as a combination component.
What research teams should watch
Record the primary site, resectability and partner drugs so the treatment is classified accurately.
PRIMARY RECORDS